Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

209 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Novel drugs approved by the EMA, the FDA, and the MHRA in 2023: A year in review.
Papapetropoulos A, Topouzis S, Alexander SPH, Cortese-Krott M, Kendall DA, Martemyanov KA, Mauro C, Nagercoil N, Panettieri RA Jr, Patel HH, Schulz R, Stefanska B, Stephens GJ, Teixeira MM, Vergnolle N, Wang X, Ferdinandy P. Papapetropoulos A, et al. Among authors: vergnolle n. Br J Pharmacol. 2024 Jun;181(11):1553-1575. doi: 10.1111/bph.16337. Epub 2024 Mar 22. Br J Pharmacol. 2024. PMID: 38519837 Review.
Planning experiments: Updated guidance on experimental design and analysis and their reporting III.
Curtis MJ, Alexander SPH, Cirino G, George CH, Kendall DA, Insel PA, Izzo AA, Ji Y, Panettieri RA, Patel HH, Sobey CG, Stanford SC, Stanley P, Stefanska B, Stephens GJ, Teixeira MM, Vergnolle N, Ahluwalia A. Curtis MJ, et al. Among authors: vergnolle n. Br J Pharmacol. 2022 Aug;179(15):3907-3913. doi: 10.1111/bph.15868. Epub 2022 Jun 7. Br J Pharmacol. 2022. PMID: 35673806 Free article.
Considering and reporting sex as an experimental variable II: An update on progress in the British Journal of Pharmacology.
Stanford SC, Alexander S, Cirino G, George CH, Insel PA, Kendall D, Ji Y, Panettieri RA Jr, Patel HH, Sobey CG, Stefanska B, Stephens G, Teixeira M, Vergnolle N, Ferdinandy P, Ahluwalia A. Stanford SC, et al. Among authors: vergnolle n. Br J Pharmacol. 2023 May;180(9):1191-1196. doi: 10.1111/bph.16049. Epub 2023 Mar 6. Br J Pharmacol. 2023. PMID: 36876456 Free article. No abstract available.
Recent changes in the British Journal of Pharmacology: widening scope and improving author and editor experience.
Papapetropoulos A, Alexander SPH, Cortese-Krott M, Kendall DA, Martemyanov K, Mauro C, Panettieri RA Jr, Patel HH, Schulz R, Stefanska B, Stephens GJ, Teixeira MM, Vergnolle N, Wang XJ, Ferdinandy P. Papapetropoulos A, et al. Among authors: vergnolle n. Br J Pharmacol. 2023 Sep;180(17):2193-2195. doi: 10.1111/bph.16169. Epub 2023 Jul 18. Br J Pharmacol. 2023. PMID: 37462063 No abstract available.
Chymotrypsin activity signals to intestinal epithelium by protease-activated receptor-dependent mechanisms.
Guignard S, Saifeddine M, Mihara K, Motahhary M, Savignac M, Guiraud L, Sagnat D, Sebbag M, Khou S, Rolland C, Edir A, Bournet B, Buscail L, Buscail E, Alric L, Camare C, Ambli M, Vergnolle N, Hollenberg MD, Deraison C, Bonnart C. Guignard S, et al. Among authors: vergnolle n. Br J Pharmacol. 2024 Apr 18. doi: 10.1111/bph.16341. Online ahead of print. Br J Pharmacol. 2024. PMID: 38637276
Protease-activated receptor-4: a novel mechanism of inflammatory pain modulation.
Asfaha S, Cenac N, Houle S, Altier C, Papez MD, Nguyen C, Steinhoff M, Chapman K, Zamponi GW, Vergnolle N. Asfaha S, et al. Among authors: vergnolle n. Br J Pharmacol. 2007 Jan;150(2):176-85. doi: 10.1038/sj.bjp.0706975. Epub 2006 Dec 18. Br J Pharmacol. 2007. PMID: 17179954 Free PMC article.
209 results